Robert KratzkeRuth O’ ReganMembers of the Big Ten Cancer Research Consortium steering committee appointed Robert Kratzke as the committee's first chair and Ruth O'Regan as its vice chair. Each will serve a one-year term, with O'Regan serving as chair in the subsequent year.
The Patient-Centered Outcomes Research Institute Board of Governors has green-lighted nearly $42 million to fund 19 new studies comparing which healthcare approaches work best.
ST. JUDE CHILDREN'S RESEARCH HOSPITAL opened its Red Frog Events Proton Therapy Center, the first proton therapy center in the world dedicated solely to children with cancer.
MONICA BERTAGNOLLI was elected president of the American Society of Clinical Oncology for the term beginning in June 2018.
JEFFREY DREBIN was named chair of surgery at Memorial Sloan Kettering Cancer Center, a position he will assume early next year. He is the chair of the Department of Surgery at Penn Medicine and the 14th John Rhea Barton Professor of Surgery at the Perelman School of Medicine.
RAVI SALGIA, chair of City of Hope’s Department of Medical Oncology and Therapeutic Research, was awarded the 2016 Asclepius Award from the Bonnie J. Addario Lung Cancer Foundation for his decades-long work in treating lung cancer patients and researching new therapies. Salgia joined City of Hope in January 2016, where he’s led the expansion of... […]
THE PROSTATE CANCER FOUNDATION and the U.S Department of Veterans Affairs will collaborate on a $50 million precision medicine initiative aimed at expanding prostate cancer clinical research among veterans and speed the development of new treatment options and cures for prostate cancer patients. The PCF-VA agreement was signed as part of Launch Pad: Pathways to... […]
NCCN has published NCCN Imaging Appropriate Use Criteria for an additional 15 NCCN Clinical Practice Guidelines in Oncology. Launched in June 2016, NCCN Imaging AUC currently are available for 35 NCCN Guidelines. NCCN Imaging AUC are an easy-to-use, single source for AUC pertaining to cancer screening, diagnosis, staging, treatment response assessment, follow-up, and surveillance as... […]
DANIEL DIETRICK was named chief value officer at Chesapeake Urology. His primary function is to oversee patient safety and healthcare quality. He will execute on the overall clinical vision and strategy of the organization, maintaining professional and quality control standards, and creating and overseeing processes to improve quality, efficiency, and cost effectiveness in Chesapeake Urology’s... […]
SOUTHERN RESEARCH was awarded a five-year Indefinite-Delivery Indefinite-Quantity contract from NCI. This is to investigate the pharmacokinetic properties of antitumor and other therapeutic agents of interest to the Division of Cancer Treatment and Diagnosis (DCTD) under NCI contract HHSN261201600021I. RFP number N02CM67000-11 was issued under full and open competition, which resulted in five IDIQ awards.... […]
